394 related articles for article (PubMed ID: 19046207)
1. Chronic complications and mortality in community-based patients with latent autoimmune diabetes in adults: the Fremantle Diabetes Study.
Myhill P; Davis WA; Bruce DG; Mackay IR; Zimmet P; Davis TM
Diabet Med; 2008 Oct; 25(10):1245-50. PubMed ID: 19046207
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of LADA and frequency of GAD antibodies in diabetic patients with end-stage renal disease and dialysis treatment in Austria.
Biesenbach G; Auinger M; Clodi M; Prischl F; Kramar R;
Nephrol Dial Transplant; 2005 Mar; 20(3):559-65. PubMed ID: 15671073
[TBL] [Abstract][Full Text] [Related]
3. The clinical characteristics of latent autoimmune diabetes in adults and its relation with chronic complications in metabolically poor controlled Turkish patients with Type 2 diabetes mellitus.
Arikan E; Sabuncu T; Ozer EM; Hatemi H
J Diabetes Complications; 2005; 19(5):254-8. PubMed ID: 16112499
[TBL] [Abstract][Full Text] [Related]
4. Glutamic acid decarboxylase 65 autoantibody levels discriminate two subtypes of latent autoimmune diabetes in adults.
Li X; Yang L; Zhou Z; Huang G; Yan X
Chin Med J (Engl); 2003 Nov; 116(11):1728-32. PubMed ID: 14642146
[TBL] [Abstract][Full Text] [Related]
5. [Glutamic acid decarboxylase and tyrosine phosphatase-like IA-2 antibodies for diabetes classification in unselected diabetic patients].
Reinsch B; Zimmy S; Schatz H; Pfohl M
Med Klin (Munich); 2003 Feb; 98(2):67-71. PubMed ID: 12601530
[TBL] [Abstract][Full Text] [Related]
6. Clinical and genetic characteristics of diabetic patients with high-titer (>10,000 U/ml) of antibodies to glutamic acid decarboxylase.
Ishii M; Hasegawa G; Fukui M; Obayashi H; Ohta M; Ogata M; Yoshioka K; Kitagawa Y; Nakano K; Yoshikawa T; Nakamura N
Immunol Lett; 2005 Jul; 99(2):180-5. PubMed ID: 16009268
[TBL] [Abstract][Full Text] [Related]
7. [Value of glutamic acid decarboxylase autoantibody detection for early diagnosis of latent autoimmune diabetes in adults].
Huang YY; Huang P; Lou HL
Di Yi Jun Yi Da Xue Xue Bao; 2003 Aug; 23(8):868-9. PubMed ID: 12919925
[TBL] [Abstract][Full Text] [Related]
8. [Islet beta cell function in latent autoimmune diabetes in adults with islet cell antibodies].
Yang L; Zhou ZG; Huang G; Yan X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 29(3):309-14. PubMed ID: 16136967
[TBL] [Abstract][Full Text] [Related]
9. Latent autoimmune diabetes in Tunisian adults (LADA): identification of autoimmune markers.
Amrouche Ch; Jamoussi Kamoun H; Trabelsi N; Blouza Chabchoub S
Tunis Med; 2008 Apr; 86(4):316-8. PubMed ID: 19476130
[TBL] [Abstract][Full Text] [Related]
10. GAD antibodies in probands and their relatives in a cohort clinically selected for Type 2 diabetes.
Castleden HA; Shields B; Bingley PJ; Williams AJ; Sampson M; Walker M; Gibson JM; McCarthy MI; Hitman GA; Levy JC; Hattersley AT; Vaidya B; Pearson ER
Diabet Med; 2006 Aug; 23(8):834-8. PubMed ID: 16911619
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and clinical characteristics of insulin-treated, anti-GAD-positive, type 2 diabetic subjects in an outpatient clinical department of a Dutch teaching hospital.
Römkens TE; Kusters GC; Netea MG; Netten PM
Neth J Med; 2006 Apr; 64(4):114-8. PubMed ID: 16609158
[TBL] [Abstract][Full Text] [Related]
12. Anti-CD38 autoantibodies: characterisation in new-onset type I diabetes and latent autoimmune diabetes of the adult (LADA) and comparison with other islet autoantibodies.
Mallone R; Ortolan E; Pinach S; Volante M; Zanone MM; Bruno G; Baj G; Lohmann T; Cavallo-Perin P; Malavasi F
Diabetologia; 2002 Dec; 45(12):1667-77. PubMed ID: 12488956
[TBL] [Abstract][Full Text] [Related]
13. A clinically orientated approach increases the efficiency of screening for latent autoimmune diabetes in adults (LADA) in a large clinic-based cohort of patients with diabetes onset over 50 years.
Monge L; Bruno G; Pinach S; Grassi G; Maghenzani G; Dani F; Pagano G
Diabet Med; 2004 May; 21(5):456-9. PubMed ID: 15089790
[TBL] [Abstract][Full Text] [Related]
14. Glutamic acid decarboxylase autoantibody prevalence and association with HLA genotype in patients with younger-onset type 1 diabetes and proliferative diabetic retinopathy.
Mimura T; Funatsu H; Uchigata Y; Kitano S; Shimizu E; Amano S; Yamagami S; Noma H; Araie M; Hori S
Ophthalmology; 2005 Nov; 112(11):1904-9. PubMed ID: 16157380
[TBL] [Abstract][Full Text] [Related]
15. [Association of autoantibody and cytokines with latent autoimmune diabetes in adults].
He FP
Di Yi Jun Yi Da Xue Xue Bao; 2003 Dec; 23(12):1323-5. PubMed ID: 14678903
[TBL] [Abstract][Full Text] [Related]
16. Diabetic neuropathy in patients with "latent autoimmune diabetes of the adults" (LADA) compared with patients with type 1 and type 2 diabetes.
Baum P; Hermann W; Verlohren HJ; Wagner A; Lohmann T; Grahmann F
J Neurol; 2003 Jun; 250(6):682-7. PubMed ID: 12796829
[TBL] [Abstract][Full Text] [Related]
17. Equivalent insulin resistance in latent autoimmune diabetes in adults (LADA) and type 2 diabetic patients.
Chiu HK; Tsai EC; Juneja R; Stoever J; Brooks-Worrell B; Goel A; Palmer JP
Diabetes Res Clin Pract; 2007 Aug; 77(2):237-44. PubMed ID: 17234296
[TBL] [Abstract][Full Text] [Related]
18. Carboxypeptidase-H autoantibodies differentiate a more latent subset of autoimmune diabetes from phenotypic type 2 diabetes among Chinese adults.
Yang L; Zhou ZG; Tan SZ; Huang G; Jin P; Yan X; Li X; Peng H; Hagopian W
Ann N Y Acad Sci; 2008 Dec; 1150():263-6. PubMed ID: 19120309
[TBL] [Abstract][Full Text] [Related]
19. Does self-monitoring of blood glucose improve outcome in type 2 diabetes? The Fremantle Diabetes Study.
Davis WA; Bruce DG; Davis TM
Diabetologia; 2007 Mar; 50(3):510-5. PubMed ID: 17237940
[TBL] [Abstract][Full Text] [Related]
20. A clinical screening tool identifies autoimmune diabetes in adults.
Fourlanos S; Perry C; Stein MS; Stankovich J; Harrison LC; Colman PG
Diabetes Care; 2006 May; 29(5):970-5. PubMed ID: 16644622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
